Tag: Ovarian Cancer

Durvalumab combined with chemotherapy improves overall survival in patients with lung cancer: First-line treatment reduces mortality risk by 27%

Adding immunotherapy in the form of durvalumab to chemotherapy improves overall survival in patients with extensive-stage small cell lung cancer, according to research presented today at the IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer (IASLC). The research was presented by Dr. Luis Paz-Ares, from

New pathogens in beef and cow’s milk products

According to the DKFZ, they have been detected up to now in cow’s milk, cow’s milk products and the blood serum of healthy cattle. From the scientific findings made up to now, it seems possible that an indirect connection could be interpreted between the consumption of various foods originating from cattle and the occurrence of

Macrophages’ pathway to nurture PTEN-deficient glioblastoma

A common genetic deficiency empowers glioblastoma to broadcast a molecular message to the wrong type of immune cell, summoning macrophages that protect and nurture the brain tumor instead of attacking it, researchers at The University of Texas MD Anderson Cancer Center report in Cancer Cell. The team’s work in mouse models of glioblastoma that lack

Georgios N. Papanikolaou, His invention saves numerous lives

New Test for the diagnosis of ovarian cancer? On the occasion of the 136. Birthday of the pathologist and inventor of the so-called Pap-smear, Georgios N. Papanikolaou, celebrates Google the doctors with a own Icon. A new Test for the effective diagnosis of uterine body cancer and ovarian cancer was developed, which is based on

Image-based computer model reveals finer details of tumor blood flow

Johns Hopkins Medicine researchers say they have developed something akin to a “Google Maps” approach for more accurately computing and visualizing the structural and functional blood vessel changes needed for tumor growth. By pairing high-quality 3D imaging data of tumor specimens from animal models with sophisticated mathematical formulas, the researchers say they now have a

Breakthrough in knowledge of how some sarcomas arise

The origin of certain cancers in the sarcoma group is associated with a hitherto unknown interaction among different proteins. Findings now being presented create the opportunity to test new treatments of these forms of sarcoma. “We now know which mechanisms to shine the spotlight on,” says Pierre Åman, Professor of Tumor Biology at Sahlgrenska Academy,

Bacterial therapy tolerable, shows early promise in patients with advanced solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to data presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3. “Even after a

Researchers compare chemotherapy regimens for best outcomes in invasive bladder cancer: Less-frequently used combination associated with better response than standard of care

Patients with muscle-invasive bladder cancer have been shown to benefit from chemotherapy prior to surgical removal of the bladder. But which type of chemotherapy leads to the best outcomes in terms of complete response rates or cancer control? Moffitt Cancer Center researchers examined data from more than 800 surgical patients with advanced bladder cancer. The

Mechanisms of action of key genetic abnormality in Ewing sarcoma: Epigenome editing reveals how a fusion protein found in cancer cells enhances the expression of target genes

A Massachusetts General Hospital (MGH) research team has used epigenome editing tools to investigate how the genetic abnormality that drives Ewing sarcoma — the second most common bone cancer in children and young adults — unleashes tumor growth. In their paper in the journal Genes & Development the researchers show that blocking the fusion protein

Different outdoor professions carry different risks for skin cancer

One of the main risk factors for non-melanoma skin cancer (NMSC), the most common cancer worldwide, is solar ultraviolet radiation. A new Journal of the European Academy of Dermatology and Venereology study has found that different outdoor professions carry different risks for NMSC. In the study of 563 participants (47% women) consisting of 348 outdoor

Childhood cancer: The four survival strategies of tumor cells

Cancer cells in children tend to develop by following four main trajectories — and two of them are linked to relapse of the disease, research led by Lund University in Sweden shows. The four strategies can occur simultaneously in a single tumour, according to the study that is now published in Nature Genetics. The researchers

Cancer cells co-opt pain-sensing ‘wasabi receptor’ to survive oxidative stress: Antioxidants and the TRPA1 channel protein complement each other to increase tumor survival

Anyone who’s taken a bite of a sandwich with too much spicy mustard or a piece of sushi with too much wasabi can attest to the tear-inducing sensation these condiments can cause. These loud warnings to the nervous system of exposure to potentially harmful chemicals are triggered by TRPA1, a calcium channel protein sometimes referred